Lawmakers are accusing the manufacturers of popular weight loss medications of price gouging U.S. consumers and the government. They are pressing for answers on why Ozempic and Wegovy can cost up to 15 times more in the United States than in other countries. This hearing comes in light of new research indicating a concerning rise in severe obesity rates across the U.S. CGTN’s Owen Fairclough has the latest details.